Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study

Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study

Background: The breakthrough development of novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines and oral antivirals have played a critical role in curtailing the spread of the pandemic and dramatically reducing the morbidity and mortality rates among those infected. Among the...

Full description

Bibliographic Details
Main Authors: Xue Zhong, Chao Wang, Lin Huang, Yue Zhao, Tianyi Li, Jing He, Xiaohong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Pharmacology
Subjects:
nirmatrelvir-ritonavir
rheumatic disease
coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
real-world study
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1288402/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1288402/full

Similar Items